Juan Luis Santiago, Eva Maria Galan-Moya, Jose Ramon Muñoz-Rodriguez, et al. Topical Applications of Thiosulfinate-Enriched Allium sativum Extract Accelerates Acute Cutaneous Wound Healing in Murine Model. [J]. Chinese Journal of Integrative Medicine 26(11):812-818(2020)
DOI:
Juan Luis Santiago, Eva Maria Galan-Moya, Jose Ramon Muñoz-Rodriguez, et al. Topical Applications of Thiosulfinate-Enriched Allium sativum Extract Accelerates Acute Cutaneous Wound Healing in Murine Model. [J]. Chinese Journal of Integrative Medicine 26(11):812-818(2020) DOI: 10.1007/s11655-020-3086-7.
Topical Applications of Thiosulfinate-Enriched Allium sativum Extract Accelerates Acute Cutaneous Wound Healing in Murine Model
摘要
Abstract
Objective:
2
To determine whether topical applications of thiosulfinate-enriched
Allium sativum
extract (TASE) can accelerate acute cutaneous wound healing (WH) in a murine model.
Methods:
2
Keratinocyte viability and
in vitro
wound closure were assessed in keratinocyte cultures. Effects of topical TASE (0.5 μg/mL of allicin in 97% ethanol) on acute cutaneous WH were determined in a murine model of acute cutaneous wound. Twelve mice were alternately assigned to the vehicle- and TASE-treated groups (
n
=6 per group). Expression levels of mRNA for keratinocyte differentiation marker-related proteins (filaggrin
loricrin and involucrin) and lipid synthetic enzymes (elongation of very long chain fatty acids protein 4 (ELOVL4)
fatty acid synthase (FA2H)
3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMGCoA)
and serine palmitoyltransferase (SPT)) were assessed using real-time quantitative polymerase chain reaction on day 3 and 8 after wounding
while transepidermal water loss (TEWL) rates were measured in wounded areas.
Results:
2
TASE accelerated WH both
in vivo
(40% vs. 22% reduction in wound area
P
<
0.01) and
in vitro
(90% vs. 65% reduction in wound area
P
<
0.01). Moreover
topical applications of TASE upregulated the expression levels of epidermal mRNA for ELOVL4
HMGCoA
SPT
filaggrin
loricrin and involucrin (
P
<
0.05 vs. vehicle-treated controls) on day 3 after wounding. Likewise
TASE significantly lowered TEWL rates in comparison with vehicle alone on day 8 (33.06±2.09 g/(m
2
•h) vs. 24.60±2.04 g/(m
2
•h)
P
<
0.01).
Conclusions:
2
Topical applications of TASE stimulated keratinocyte proliferation and formation of epidermal permeability barrier function
leading to acceleration of acute cutaneous WH. Topical products containing TASE could be used to manage acute cutaneous WH.